Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease

Br J Haematol. 1998 Nov;103(2):533-5. doi: 10.1046/j.1365-2141.1998.00989.x.

Abstract

Twenty-six patients with relapsed or refractory Hodgkin's disease (HD) were treated with an intensive salvage regimen combining ifosfamide (3000 mg/m2/d, days 1-4 through continuous intravenous infusion) and vinorelbine (25 mg/m2, i.v. days 1 and 5) with mesna uroprotection and G-CSF support. Courses were given at 3-week intervals. Ten patients achieved a complete and 10 patients a partial response, yielding an overall response rate of 77%. The main toxic effect was neutropenia and the combination was well tolerated.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Hodgkin Disease / drug therapy*
  • Humans
  • Ifosfamide / administration & dosage
  • Male
  • Middle Aged
  • Neutropenia / chemically induced
  • Pilot Projects
  • Recurrence
  • Salvage Therapy
  • Treatment Outcome
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives
  • Vinorelbine

Substances

  • Vinblastine
  • Vinorelbine
  • Ifosfamide